PROMPT REMISSION OF POSTRENAL TRANSPLANT NEPHROTIC SYNDROME WITH HIGH-DOSE CYCLOSPORINE

被引:19
|
作者
SRIVASTAVA, RN [1 ]
KALIA, A [1 ]
TRAVIS, LB [1 ]
DIVEN, SC [1 ]
GUGLIUZZA, KK [1 ]
RAJARAMAN, S [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,DEPT PEDIAT,GALVESTON,TX 77555
关键词
RECURRENT NEPHROTIC SYNDROME; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CYCLOSPORINE A; RENAL TRANSPLANTATION;
D O I
10.1007/BF00868281
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A 2.8-year-old girl with focal segmental glomerulosclerosis had recurrence of nephrotic syndrome within 3 days of renal transplantation and the serum creatinine increased. Renal biopsy showed cellular rejection and also complete effacement of the epithelial cell foot processes. The rejection responded to methylprednisolone therapy but massive proteinuria persisted. An increase in the dose of cyclosporine A to 14 mg/kg per day was followed by immediate remission of the proteinuria. One month later, a second renal biopsy showed only focal fusion of foot processes. She remains free of proteinuria 2 years later. We propose that the higher dose of cyclosporine caused remission of the nephrotic syndrome.
引用
收藏
页码:94 / 95
页数:2
相关论文
共 50 条
  • [41] Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome
    Hegarty, J
    Mughal, MZ
    Adams, J
    Webb, NJA
    KIDNEY INTERNATIONAL, 2005, 68 (05) : 2304 - 2309
  • [42] Early high-dose immunosuppression in Henoch-Schonlein nephrotic syndrome may improve outcome
    Andersen, R. F.
    Rubak, S.
    Jespersen, B.
    Rittig, S.
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2009, 43 (05): : 409 - 415
  • [43] The Excellent Results of High-Dose Mizoribine Combined with Cyclosporine, Basiliximab and Corticosteroid in Renal Transplant Patients.
    Yoshimura, Norio
    Suzuki, Tomoyuki
    Fujiki, Masato
    Nobori, Syuji
    Ushigome, Hidetaka
    Sakamoto, Seisuke
    Okamoto, Masahiko
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 410 - 410
  • [44] CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen
    Thibault, Gilles
    Paintaud, Gilles
    Legendre, Christophe
    Merville, Pierre
    Coulon, Maxime
    Chasseuil, Elodie
    Ternant, David
    Rostaing, Lionel
    Durrbach, Antoine
    Di Giambattista, Fabienne
    Buechler, Matthias
    Lebranchu, Yvon
    TRANSPLANT INTERNATIONAL, 2016, 29 (02) : 184 - 195
  • [45] High dose methylprednisolone therapy in nephrotic syndrome
    Mocan H.
    Erduran E.
    Karagüzel G.
    The Indian Journal of Pediatrics, 1999, 66 (2) : 171 - 174
  • [46] Remission of nephrotic membranous glomerulonephritis after high-dose trimethoprim-sulfamethoxazole treatment case for Pneumocystis jiroveci pneumonia
    Wen, Y. K.
    Chen, M. L.
    CLINICAL NEPHROLOGY, 2007, 68 (02) : 99 - 103
  • [47] A RANDOMIZED CONTROLLED TRIAL OF LOW-DOSE PREDNISONE AND CICLOSPORIN VERSUS HIGH-DOSE PREDNISONE IN NEPHROTIC SYNDROME OF CHILDREN
    TEJANI, A
    SUTHANTHIRAN, M
    POMRANTZ, A
    NEPHRON, 1991, 59 (01): : 96 - 99
  • [48] GOODPASTURES-SYNDROME - RAPID REMISSION AFTER EARLY PLASMAPHERESIS AND HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY
    EULER, HH
    KLEINE, L
    GUTSCHMIDT, HJ
    HERRLINGER, JD
    KLINISCHE WOCHENSCHRIFT, 1982, 60 (12): : 635 - 636
  • [49] Cyclosporine (Cs) induced remission of relapsing minimal change nephrotic syndrome (MCNS) in adults.
    Choi, EJ
    Kim, SY
    Chang, YS
    Bang, BK
    KIDNEY INTERNATIONAL, 1997, 51 (03) : 946 - 946
  • [50] Effects of cyclosporine on bone mineral density in patients with glucocorticoid-dependent nephrotic syndrome in remission
    Shimizu, Chie
    Fujita, Takayuki
    Fuke, Yoshinobu
    Yabuki, Minako
    Kajiwara, Mamiko
    Hemmi, Seiichiro
    Satomura, Atsushi
    Soma, Masayoshi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (03) : 803 - 808